Yongqi Ding, Yiyang Gong, Hong Zeng, Xuanrui Zhou, Zichuan Yu, Jingying Pan, Minqin Zhou, Shiwen Liu, Wei Lai
Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer, with a high morbidity and low survival rate. Rho GTPase activating protein 39 (ARHGAP39) is a crucial activating protein of Rho GTPases, a novel target in cancer therapy, and it was identified as a hub gene for gastric cancer. However, the expression and role of ARHGAP39 in hepatocellular carcinoma remain unclear. Accordingly, the cancer genome atlas (TCGA) data were used to analyze the expression and clinical value of ARHGAP39 in hepatocellular carcinoma...
April 5, 2023: Aging